Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$848M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$631M |
| 3 |
Truist Financial
TFC
|
+$445M |
| 4 |
Amazon
AMZN
|
+$334M |
| 5 |
ServiceNow
NOW
|
+$251M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.15B |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$466M |
| 3 |
VIAB
Viacom Inc. Class B
VIAB
|
+$139M |
| 4 |
Oracle
ORCL
|
+$136M |
| 5 |
Intuitive Surgical
ISRG
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.79% |
| 2 | Financials | 15.45% |
| 3 | Healthcare | 13.87% |
| 4 | Consumer Discretionary | 9.9% |
| 5 | Industrials | 9.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
Geron
GERN
$994M
| $3.36M | ﹤0.01% |
2,473,903
+117,423
| +5% | +$170K |
|
2652
Standard BioTools
LAB
$309M
| $3.36M | ﹤0.01% |
966,667
-40,667
| -4% | -$143K |
|
|
PARAA
2653
DELISTED
Paramount Global Class A
PARAA
| $3.36M | ﹤0.01% |
+74,974
| New | +$3.18M |
|
2654
Neurogene
NGNE
$728M
| $3.35M | ﹤0.01% |
13,610
+5,079
| +60% | +$506K |
|
|
VRTV
2655
DELISTED
VERITIV CORPORATION
VRTV
| $3.35M | ﹤0.01% |
170,456
+10,288
| +6% | +$180K |
|
|
BRT
2656
BRT Apartments
BRT
$271M
| $3.35M | ﹤0.01% |
197,360
+475
| +0.2% | +$7.99K |
|
2657
Nuveen Credit Strategies Income Fund
JQC
$720M
| $3.35M | ﹤0.01% |
436,667
+167,974
| +63% | +$1.25M |
|
|
CDR
2658
DELISTED
Cedar Realty Trust, Inc
CDR
| $3.35M | ﹤0.01% |
172,027
+6,525
| +4% | +$127K |
|
2659
Apyx Medical
APYX
$124M
| $3.35M | ﹤0.01% |
395,670
+12,580
| +3% | +$90.9K |
|
2660
LifeVantage
LFVN
$81M
| $3.34M | ﹤0.01% |
213,793
+24,811
| +13% | +$365K |
|
2661
SIGA Technologies
SIGA
$208M
| $3.33M | ﹤0.01% |
699,056
+53,842
| +8% | +$274K |
|
|
SMMF
2662
DELISTED
Summit Financial Group, Inc.
SMMF
| $3.33M | ﹤0.01% |
123,084
+858
| +0.7% | +$22.6K |
|
|
DNI
2663
DELISTED
Dividend and Income Fund
DNI
| $3.33M | ﹤0.01% |
247,313
-28,290
| -10% | -$352K |
|
|
WTRE
2664
DELISTED
Watford Holdings Ltd. Common Shares
WTRE
| $3.32M | ﹤0.01% |
131,965
-2,276
| -2% | -$60.5K |
|
|
HALL
2665
DELISTED
Hallmark Financial Services, Inc.
HALL
| $3.3M | ﹤0.01% |
18,788
-56
| -0.3% | -$10.2K |
|
2666
Geospace Technologies
GEOS
$66.2M
| $3.3M | ﹤0.01% |
196,636
+6,302
| +3% | +$95.7K |
|
2667
United Microelectronic
UMC
$49.2B
| $3.29M | ﹤0.01% |
1,215,126
+298,133
| +33% | +$720K |
|
2668
Ooma
OOMA
$559M
| $3.29M | ﹤0.01% |
249,049
+10,627
| +4% | +$129K |
|
2669
Preformed Line Products
PLPC
$2.26B
| $3.29M | ﹤0.01% |
54,455
-1,997
| -4% | -$124K |
|
|
SYRS
2670
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $3.29M | ﹤0.01% |
47,555
+2,412
| +5% | +$146K |
|
|
CONN
2671
DELISTED
Conn's Inc.
CONN
| $3.29M | ﹤0.01% |
265,140
+12,231
| +5% | +$256K |
|
2672
Rocky Brands
RCKY
$354M
| $3.28M | ﹤0.01% |
111,424
-1,300
| -1% | -$38.3K |
|
2673
MVB Financial
MVBF
$396M
| $3.27M | ﹤0.01% |
131,442
-14,528
| -10% | -$308K |
|
2674
Minerva Neurosciences
NERV
$190M
| $3.27M | ﹤0.01% |
57,505
+3,879
| +7% | +$171K |
|
2675
MannKind Corp
MNKD
$1.18B
| $3.27M | ﹤0.01% |
2,534,182
+95,206
| +4% | +$122K |
|
Similar funds
Geode Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, Geode Capital Management held 4,322 positions worth $478B, up 12% from $428B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Geode Capital Management's Q4 2019 filing shows 132 new, 3,091 increased, 523 reduced and 113 closed positions. Its largest new stake was Apollo Global Management: 1,482,213 shares worth $70.7M. The largest sale was Celgene Corp, an estimated $1.15B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q4 2019 buy was Apollo Global Management: 1,482,213 shares worth $70.7M.
- Geode Capital Management added most to Microsoft in Q4 2019, an estimated $848M increase.
- Geode Capital Management's biggest Q4 2019 reduction was Oracle, cutting an estimated $136M.
- Geode Capital Management fully exited Celgene Corp in Q4 2019, selling an estimated $1.15B.
- Geode Capital Management's ten largest holdings make up 19% of its $478B portfolio in Q4 2019.
- Geode Capital Management opened 132 new positions and closed 113 in Q4 2019.
- Geode Capital Management's portfolio value rose 12% quarter-over-quarter to $478B.
Based on Geode Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.